Drug Trial Radar · NCT05251090
A Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII ,Fc Fusion Protein for Injection
Last checked: Nov 19, 2026Latest source record: Aug 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
13
Actual
Start
Jun 16, 2021
Primary completion
Nov 15, 2021
Study completion May 9, 2022
Sponsor
- Lead sponsor
- Hangzhou Gensciences Biopharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 22, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, up to 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary objective: To assess the pharmacokinetics of Recombinant Human Coagulation Factor VIII, Fc Fusion Protein for Injection (FRSW107) Secondary objectives: To assess Safety and Tolerability by monitoring FVIII recovery and adverse events in Severe Hemophilia A.
Conditions
- Hemophilia A
Interventions
ADVATEDrug
50 international units (IU)/kg, a single dose.
FRSW107Drug
50 IU/kg, a single dose.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum measured concentration of FVIII:C (Cmax)Time frame: Pre-dose and post dose up to 8 days.
- Time required for the concentration of the drug to reach half of its original value (T1/2)Time frame: Pre-dose and post dose up to 8 days
- Area Under the Curve to Infinity (AUC)Time frame: Pre-dose and post dose up to 8 days.
- The measure of the efficiency of the body to remove the drug and the unit is the volume of the plasma or blood cleared of drug per unit time (CL).Time frame: Pre-dose and post dose up to 8 days.
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Beijing Children's Hospital,Capital Medical University
Beijing, Beijing Municipality, China
Shenzhen Children's Hospita
Shenzhen, Guangdong, China
Nanfang Hospital of Southern Medical University
Guangzhou, Guangzhou, China
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
Wuhan, Hubei, China
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
Chengdu Women's and Children's Central Hospital
Chengdu, Sichuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.